08:00 , Nov 20, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Muscular dystrophy Latent transforming growth factor-b binding protein 4 (LTBP4) Mouse studies suggest inhibiting cleavage of LTBP4 could help treat muscular dystrophies. In mouse...